CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 88 enrolled
Drug / intervention
thoracic Drain Tube 24 Fr.device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03543462
NCT03543462Phase 4Completed
CompareCT.gov

Diaphragmatic Resection And Gynecological Ovarian Neoplasm

Catholic University of the Sacred Heart·interventional·Posted Jun 1, 2018·Updated May 22, 2020

In Brief

A Phase 4 clinical trial evaluating thoracic Drain Tube 24 Fr. for Ovarian Cancer. Completed, enrolled 88 participants across 1 site.

Detailed Summary

Prospective randomized phase IV study aimed to value the impact of diaphragmatic surgery and the useful of intra-operatory thoracic drain in advanced ovarian cancer. Considering the fact that the diaphragmatic surgery could contribute with the incidence of post-operatory morbidity. The study is aimed to value the role of thoracic drain in post-operative outcomes as hospital stay, time to chemotherapy, drugs use and eventual interventions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOvarian Cancer
CountriesItaly
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedJun 1, 2018
Enrollment StartMar 20, 2018
Primary CompletionNov 11, 2019
Study CompletionJan 11, 2020
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 8.1 years ago

Interventions

thoracic Drain Tube 24 Fr.device

Positioning of Thoracic Drain after diaphragmatic resection and consequently diaphragmatic repair